Brind.
  1. IGC Pharma, Inc. is leveraging AI platforms like MINT-AD for drug discovery, coinciding with the AAIC 2025 conference in Toronto.

IGC Pharma, Inc. is currently developing treatments specifically targeting Alzheimer's dementia.

1 report, 1 independent Updated Jun 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

IGC Pharma, Inc. is currently developing treatments specifically targeting Alzheimer's dementia.

Keep exploring

Part of

IGC Pharma, Inc. is leveraging AI platforms like MINT-AD for drug discovery, coinciding with the AAIC 2025 conference in Toronto. All 2 developments

Coverage

Newest first; wire copies grouped